Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GLMD

Galmed Pharmaceuticals Ltd

May 29 • 04:00PM ET

0.7536

+0.0761 11.23 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.33	Insider Own	3.70%	Shs Outstand	6.58M	Perf Week	29.91%
Market Cap	4.97M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	0.00%	Shs Float	6.36M	Perf Month	34.55%
Enterprise Value	-13.31M	PEG	-	EPS next Q	-0.39	Inst Own	4.84%	Short Float	0.91%	Perf Quarter	23.24%
Income	-10.31M	P/S	-	EPS this Y	34.73%	Inst Trans	-1.84%	Short Ratio	0.02	Perf Half Y	-8.31%
Sales	0.00M	P/B	0.31	EPS next Y	42.31%	ROA	-55.53%	Short Interest	0.06M	Perf YTD	0.41%
Book/sh	2.40	P/C	0.27	EPS next 5Y	31.74%	ROE	-64.21%	52W High	2.34 -67.79%	Perf Year	-47.30%
Cash/sh	2.77	P/FCF	-	EPS past 3/5Y	73.46% 60.33%	ROIC	-65.32%	52W Low	0.41 83.31%	Perf 3Y	-98.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.94% 9.34%	Perf 5Y	-99.84%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	74.58%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-99.89%
Dividend Ex-Date	-	Quick Ratio	6.55	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	66.34	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.55	EPS Q/Q	62.02%	SMA20	23.17%	Beta	0.69	Target Price	12.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	21.70%	Rel Volume	0.09	Prev Close	0.68
Employees	6	LT Debt/Eq	0.00	Earnings	May 20	SMA200	-20.77%	Avg Volume	3.05M	Price	0.75
IPO	Mar 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	273,252	Change	11.23%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)